Exclusive look at our Italian contribution to The Life Sciences Law Review

The fourth edition of The Life Sciences Review was recently published which included valued contributions made by our IP and Life Sciences group in Italy.

Our chapter provides an overview of legal issues of interest to pharmaceutical, biotechnology and medical device companies in the Italian market. It contains information on legal requirements relating to the key stages in the life cycle of a regulated product, from discovery, through the clinical development process, registration, manufacturing and promotion, plus other issues of special interest, such as pricing and reimbursement, special liability regimes, competition and commercial transactions in the context of the medical products business.

The resulting work product will assist industry lawyers, regulatory affairs staff and others who need to have an understanding of the issues in each major market.

Please click here for the PDF version of the exclusive Italy chapter. If you would like to view the eBook or PDF version of the entire Life Sciences Law Review, please click on the image.

News & Deals

More News & Deals

News

Bird & Bird recognised in Global Arbitration Review’s "GAR 100" list

Apr 25 2025

Read More

Deal

Bird & Bird advises the L'Oréal Group on its exclusive beauty partnership with JACQUEMUS, as well as on its minority stake acquisition

Apr 24 2025

Read More

News

Bird & Bird participates in JuriAI Ring to establish world’s first AI benchmarking index for legal sector

Apr 23 2025

Read More

News

Bird & Bird strengthens leadership in Finland office to support growth ambitions

Apr 22 2025

Read More

News

First hearing for PI damages per RoP 213.2 at the UPC - another “first” for Bird & Bird and its clients NanoString/Bruker

Apr 22 2025

Read More

News

Bird & Bird China wins CBLJ "Deals of the Year 2024"

Apr 17 2025

Read More

Related capabilities